BC008-1A
- Generic Name
- BC008-1A
BC008-1A Injection for Recurrent CNS WHO G4 Glioma
Phase 1
Not yet recruiting
- Conditions
- Glioma Tumor RecurrenceGlioma, Recurrent High GradeGlioblastoma WHO Grade IVGliomaGlioblastomas (GBM)
- Interventions
- First Posted Date
- 2025-01-14
- Last Posted Date
- 2025-03-10
- Lead Sponsor
- Sichuan Luzhou Buchang Biopharmaceutical Co., Ltd.
- Target Recruit Count
- 40
- Registration Number
- NCT06773481
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath